<DOC>
	<DOCNO>NCT02941965</DOCNO>
	<brief_summary>This prospective , randomize ( 1:1 ratio ) clinical trial patient male-factor infertility without preimplantation genetic screening ( PGS ) . Qualified 650 patient randomize either two group : group A undergo intracytoplasmic sperm injection ( ICSI ) without PGS ( 325 case ) , Group B undergo ICSI PGS ( 690 case ) . The partner participant receive protocol ovarian stimulation standardize luteal phase support . The target population patient male-factor infertility age 20 50 year , diagnose ESHER Criteria ( oligospermia asthenspermia ) . Women reason infertility ( eg . anovulation , endometriosis , premature ovarian failure ) exclude . The randomization take place oocyte pick-up day computer randomization system . The pregnancy test result , pregnancy complication , congenital anomaly , neonatal complication follow check medical record telephone call .</brief_summary>
	<brief_title>Preimplantation Genetic Screening Patients With Male Factor Infertility</brief_title>
	<detailed_description />
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Infertility , Male</mesh_term>
	<criteria>1 . Male patient age 20 50 year old ; 2 . Male patient diagnose oligospermia asthenospermia accord ESHER criterion ; 3 . Male patient intend undergo ICSI sign write consent form . 1 . Male patient azoospermia , sexual dysfunction , immunological infertility ; 2 . Spouse advance age（ &gt; 35 year old） ; 3 . Spouse previously diagnose uterine abnormality malformed uterus ( uterus unicornis , septate uterus , duplex uterus uterus bicomis ) , adenomyosis , submucous myoma intrauterine adhesion ; 4 . Spouse Ovulation dysfunction related disease , endometriosis , polycystic ovarian syndrome ( tubal factor include ) ; undiagnosed infertility ; 5 . Spouse experience recurrent spontaneous abortion ( include biochemical pregnancy abortion ) , define three previous pregnancy loss ; 6 . Patients partner abnormal chromosome karyotype include chromosome polymorphism , mainly refer variant chromosomal heterochromatin region 7 . Spouse medical condition contraindicate assist reproductive technology and/or pregnancy , poorly control type 1 type 2 diabetes mellitus ; undiagnosed liver disease dysfunction ( base serum liver enzyme test result ) ; renal disease abnormal serum renal function ; significant anemia ; history deep venous thrombosis , pulmonary embolus cerebrovascular accident ; uncontrolled hypertension know symptomatic heart disease ; history ( suspect ) cervical carcinoma , endometrial carcinoma breast carcinoma ; undiagnosed vaginal bleeding ; 8 . Male patient medical condition contraindicate assist reproductive technology and/or pregnancy , poorly control type 1 type 2 diabetes mellitus ; undiagnosed liver disease dysfunction ( base serum liver enzyme test result ) ; renal disease abnormal serum renal function ; significant anemia ; history deep venous thrombosis , pulmonary embolus cerebrovascular accident ; uncontrolled hypertension know symptomatic heart disease ; 9 . Male patient partner unable comply study Procedures ; 10 . Male patient previously randomize either two study group trial .</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>